E-LIB Suche - Ergebnisse für: Toi, Norikazu

1

Time-series blood cytokine profiles correlate with treatmen..:

Saldajeno, Don Pietro ; Kawaoka, Shinpei ; Masuda, Norikazu...
British Journal of Cancer. , 2024

Link: https://doi.org/10.1038/..

2

Remarkable improvement of bone mineral density concordant w..:

Nagata, Yuki ; Sone, Kazuma ; Toi, Norikazu...
Thyroid Science. 1 (2024) 2 - p. 100013 , 2024

Link: https://doi.org/10.1016/..

3

Association Between Plasma Aldosterone Concentration and In..:

Uedono, Hideki ; Kurajoh, Masafumi ; Toi, Norikazu...
American Journal of Hypertension. , 2024

Link: https://doi.org/10.1093/..

4

Long-term outcomes of neoadjuvant trastuzumab emtansine + p..:

Takano, Toshimi ; Masuda, Norikazu ; Ito, Mitsuya...
Breast Cancer Research and Treatment. 207 (2024) 1 - p. 33-48 , 2024

Link: https://doi.org/10.1007/..

5

Phase II trial of biweekly administration with eribulin aft..:

Kobayashi, Kokoro ; Masuda, Norikazu ; Mizuno, Toshiro...
Breast Cancer Research and Treatment. 201 (2023) 3 - p. 409-415 , 2023

Link: https://doi.org/10.1007/..

6

Fulvestrant with or without anti‐HER2 therapy in patients i..:

Masuyama, Misato ; Masuda, Norikazu ; Kawaguchi, Hidetoshi...
Cancer Medicine. 12 (2023) 17 - p. 17718-17730 , 2023

Link: https://doi.org/10.1002/..

7

Improvement in the mobility of a patient with fibroblast gr..:

Toi, Norikazu ; Imanishi, Yasuo ; Nagata, Yuki...
Endocrine Journal. 70 (2023) 4 - p. 419-426 , 2023

Link: https://doi.org/10.1507/..

8

A risk-based subgroup analysis of the effect of adjuvant S-..:

Takada, Masahiro ; Imoto, Shigeru ; Ishida, Takanori...
Breast Cancer Research and Treatment. 202 (2023) 3 - p. 485-496 , 2023

Link: https://doi.org/10.1007/..

9

Fulvestrant with or without anti‐HER2 therapy in patients i..:

Misato Masuyama ; Norikazu Masuda ; Hidetoshi Kawaguchi...
https://doi.org/10.1002/cam4.6390. , 2023

Link: https://doi.org/10.1002/..

10

A risk-based subgroup analysis of the effect of adjuvant S-..:

Takada, Masahiro ; Imoto, Shigeru ; Ishida, Takanori...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564670/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Fulvestrant with or without anti‐HER2 therapy in patients i..:

Masuyama, Misato ; Masuda, Norikazu ; Kawaguchi, Hidetoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523974/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Retrospective study on the effectiveness of medroxyprogeste..:

Kawaguchi, Hidetoshi ; Yamamoto, Yutaka ; Saji, Shigehira...
Japanese Journal of Clinical Oncology. 53 (2022) 3 - p. 203-211 , 2022

Link: https://doi.org/10.1093/..

13

Immune microenvironment, homologous recombination deficienc..:

Ueno, Takayuki ; Kitano, Shigehisa ; Masuda, Norikazu...
BMC Medicine. 20 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

14

Pertuzumab retreatment for HER2‐positive advanced breast ca..:

Yamamoto, Yutaka ; Iwata, Hiroji ; Taira, Naruto...
Cancer Science. 113 (2022) 9 - p. 3169-3179 , 2022

Link: https://doi.org/10.1111/..

15

Retroperitoneal Bronchogenic Cyst Adjacent to Adrenocortica..:

Toi, Norikazu ; Kurajoh, Masafumi ; Noda, Satoru.
Internal Medicine. 61 (2022) 18 - p. 2821-2822 , 2022

Link: https://doi.org/10.2169/..